Cargando…

High dose tigecycline in critically ill patients with severe infections due to multidrug-resistant bacteria

INTRODUCTION: The high incidence of multidrug-resistant (MDR) bacteria among patients admitted to ICUs has determined an increase of tigecycline (TGC) use for the treatment of severe infections. Many concerns have been raised about the efficacy of this molecule and increased dosages have been propos...

Descripción completa

Detalles Bibliográficos
Autores principales:	De Pascale, Gennaro, Montini, Luca, Pennisi, Mariano Alberto, Bernini, Valentina, Maviglia, Riccardo, Bello, Giuseppe, Spanu, Teresa, Tumbarello, Mario, Antonelli, Massimo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4057423/ https://www.ncbi.nlm.nih.gov/pubmed/24887101 http://dx.doi.org/10.1186/cc13858

Ejemplares similares

High-dose tigecycline use in severe infections
por: De Pascale, G, et al.
Publicado: (2013)

CO(2) driven endotracheal tube cuff control in critically ill patients: A randomized controlled study
por: De Pascale, Gennaro, et al.
Publicado: (2017)

Pharmacokinetics of high-dose tigecycline in critically ill patients with severe infections
por: De Pascale, Gennaro, et al.
Publicado: (2020)

Early diagnosis of candidemia in intensive care unit patients with sepsis: a prospective comparison of (1→3)-β-D-glucan assay, Candida score, and colonization index
por: Posteraro, Brunella, et al.
Publicado: (2011)

Clinical and epidemiological risk factors for ventilator-associated pneumonia in a cohort of critically ill patients
por: De Pascale, G, et al.
Publicado: (2012)

Clinical aspects and predictors of mortality of Pseudomonas aeruginosa pneumonia in a cohort of critically ill patients
por: De Pascale, G, et al.
Publicado: (2011)

Tigecycline pharmacokinetics in critically ill patients on renal replacement therapy: possible warnings and potential perspectives for the research agenda
por: Cutuli, Salvatore Lucio, et al.
Publicado: (2020)

Clinical review: Noninvasive ventilation in the clinical setting – experience from the past 10 years
por: Antonelli, Massimo, et al.
Publicado: (2005)

Early nasal high-flow versus Venturi mask oxygen therapy after lung resection: a randomized trial
por: Pennisi, Mariano Alberto, et al.
Publicado: (2019)

The Role of Mannose-Binding Lectin in Severe Sepsis and Septic Shock
por: De Pascale, Gennaro, et al.
Publicado: (2013)

Multidrug-Resistant Pseudomonas Aeruginosa Bloodstream Infections: Analysis of Trends in Prevalence and Epidemiology
por: Tacconelli, Evelina, et al.
Publicado: (2002)

Dose of colistin: a work in progress?
por: Rocco, Monica, et al.
Publicado: (2015)

Colistin and tigecycline for management of external ventricular device-related ventriculitis due to multidrug-resistant Acinetobacter baumannii
por: Shrestha, Gentle Sunder, et al.
Publicado: (2016)

Adverse events of high-dose tigecycline in the treatment of ventilator-associated pneumonia due to multidrug-resistant pathogens
por: Chen, Zihan, et al.
Publicado: (2018)

Global Assessment of the Activity of Tigecycline against Multidrug-Resistant Gram-Negative Pathogens between 2004 and 2014 as Part of the Tigecycline Evaluation and Surveillance Trial
por: Giammanco, Anna, et al.
Publicado: (2017)

Invasive Respiratory Fungal Infections in COVID-19 Critically Ill Patients
por: Raffaelli, Francesca, et al.
Publicado: (2022)

High-Dose Tigecycline in Elderly Patients with Pneumonia Due to Multidrug-Resistant Acinetobacter baumannii in Intensive Care Unit
por: Bai, Xiang-Rong, et al.
Publicado: (2020)

Double carbapenem as a rescue strategy for the treatment of severe carbapenemase-producing Klebsiella pneumoniae infections: a two-center, matched case–control study
por: De Pascale, Gennaro, et al.
Publicado: (2017)

(1,3)-β-d-Glucan-based empirical antifungal interruption in suspected invasive candidiasis: a randomized trial
por: De Pascale, Gennaro, et al.
Publicado: (2020)

Population pharmacokinetics of tigecycline in critically ill patients
por: Luo, Xiangru, et al.
Publicado: (2023)

Best tigecycline dosing for treatment of infections caused by multidrug-resistant pathogens in critically ill patients with different body weights
por: Ibrahim, Mohamed M, et al.
Publicado: (2018)

Clinical Outcomes of Tigecycline in the Treatment of Multidrug-Resistant Acinetobacter baumannii Infection
por: Shin, Jung Ar, et al.
Publicado: (2012)

Multidrug resistant Acinetobacter nosocomial meningitis treated successfully with parenteral tigecycline
por: Wadi, Jamal Ahmad, et al.
Publicado: (2007)

Renin–angiotensin system dysregulation in critically ill patients with acute respiratory distress syndrome due to COVID-19: a preliminary report
por: Eleuteri, Davide, et al.
Publicado: (2021)

Gas conditioning during helmet noninvasive ventilation: effect on comfort, gas exchange, inspiratory effort, transpulmonary pressure and patient–ventilator interaction
por: Bongiovanni, Filippo, et al.
Publicado: (2021)

Effect of pharmacokinetic/pharmacodynamic ratio on tigecycline clinical response and toxicity in critically ill patients with multidrug-resistant Gram-negative infections
por: Ruiz, Jesus, et al.
Publicado: (2020)

Risk factors for acute kidney injury in critically ill patients receiving high intravenous doses of colistin methanesulfonate and/or other nephrotoxic antibiotics: a retrospective cohort study
por: Rocco, Monica, et al.
Publicado: (2013)

Diagnosis and Treatment of Bacterial Pneumonia in Critically Ill Patients with COVID-19 Using a Multiplex PCR Assay: A Large Italian Hospital’s Five-Month Experience
por: Posteraro, Brunella, et al.
Publicado: (2021)

Tigecycline activity against metallo-β-lactamase-producing bacteria
por: Kumar, Simit, et al.
Publicado: (2013)

Comparable Efficacy of Tigecycline versus Colistin Therapy for Multidrug-Resistant and Extensively Drug-Resistant Acinetobacter baumannii Pneumonia in Critically Ill Patients
por: Kim, Won-Young, et al.
Publicado: (2016)

Safety and effectiveness of tigecycline combination therapy in renal transplant patients with infection due to carbapenem-resistant gram-negative bacteria
por: Wang, Qin, et al.
Publicado: (2023)

The pharmacokinetics of tigecycline in critically ill adult patients undergoing CVVHD
por: Rypulak, E, et al.
Publicado: (2015)

Tigecycline Dosing Strategies in Critically Ill Liver-Impaired Patients
por: Amann, Lisa F., et al.
Publicado: (2022)

In vitro activity of tigecycline in combination with various antimicrobials against multidrug resistant Acinetobacter baumannii
por: Principe, Luigi, et al.
Publicado: (2009)

Sensitivity of levofloxacin in combination with ampicillin-sulbactam and tigecycline against multidrug-resistant Acinetobacter baumannii
por: Madadi-Goli, Nahid, et al.
Publicado: (2017)

Successful Treatment of Acute Prostatitis Caused by Multidrug-Resistant Escherichia coli With Tigecycline Monotherapy
por: Lo Priore, Elia, et al.
Publicado: (2020)

Effects of colistin and tigecycline on multidrug-resistant Acinetobacter baumannii biofilms: advantages and disadvantages of their combination
por: Sato, Yoshinori, et al.
Publicado: (2021)

Staphylococcus aureus ventilator-associated pneumonia in patients with COVID-19: clinical features and potential inference with lung dysbiosis
por: De Pascale, Gennaro, et al.
Publicado: (2021)

Multidrug Resistant Brain Abscess Due to Acinetobacter baumannii Ventriculitis Cleared by Intraventricular and Intravenous Tigecycline Therapy: A Case Report and Review of Literature
por: Long, Wenyong, et al.
Publicado: (2018)

Tigecycline Therapy for Nosocomial Pneumonia due to Carbapenem-Resistant Gram-Negative Bacteria in Critically Ill Patients Who Received Inappropriate Initial Antibiotic Treatment: A Retrospective Case Study
por: Wu, Xiaomai, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_5kvpnsu544rq205vutmikeius5